share_log

HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $7 Price Target

Moomoo 24/7 ·  Mar 19 06:48

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Leap Therapeutics (NASDAQ:LPTX) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment